Cis and trans regulation of hepcidin expression by upstream stimulatory factor

Blood

Volumn 108, Issue 13, 2006, Pages 4237-4245

  Bayele, Henry K ^b   McArdle, Harry ^b   Srai, Surjit K S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; HETERODIMER; LEUCINE ZIPPER PROTEIN; MAX PROTEIN; MYC PROTEIN; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA BINDING; E BOX ELEMENT; ENHANCER REGION; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IRON METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

EID: 33845477874     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-07-027037     Document Type: Article

References (62)

1. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
2. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150.
3. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811-7819.
4. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A. 2005;102:1906-1910.
5. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783-788.
6. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461-2463.
7. Weinstein DA, Roy CN, Fleming MD, et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776-3781.
8. Leung PS, Srai SK, Mascarenhas M, Churchill LJ, Debnam ES. Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression. Gut. 2005;54:1391-1395.
9. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110:1037-1044.
10. Vallet VS, Henrion AA, Bucchini D, et al. Glucose-dependent liver gene expression in upstream stimulatory factor 2-/- mice. J Biol Chem. 1997;272:21944-21949.
11. Vallet VS, Casado M, Henrion AA, et al. Differential roles of upstream stimulatory factors 1 and 2 in the transcriptional response of liver genes to glucose. J Biol Chem. 1998;273:20175-20179.
12. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780-8785.
13. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A. 2002;99:4596-4601.
14. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet. 2003;34:97-101.
15. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-22.
16. Mok H, Jelinek J, Pai S, et al. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development. 2004;131:1859-1868.
17. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-2093.
18. Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106:2196-2199.
19. Hentze MW, Muckenthaler M, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117:285-297.
20. Hentze MW, Kühn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A. 1996;93:8175-8182.
21. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism: cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277:41163-41170.
22. Qyang Y, Luo X, Lu T, et al. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol. 1999;19:1508-1517.
23. Luo X, Sawadogo M. Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol Cell Biol. 1996;16:1367-1375.
24. Meier JL, Luo X, Sawadogo M, Straus SE. The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol Cell Biol. 1994;14:6896-6906.
25. Qian J, Kaytor EN, Towle HC, Olson LK. Upstream stimulatory factor regulates Pdx-1 gene expression in differentiated pancreatic b-cells. Biochem J. 1999;341:315-322.
26. 2 on specificity and comparison with binding of Myc family members. Nucleic Acids Res. 1994;22:2801-2810.
27. Atchley WR, Fitch WM. A natural classification of the basic helix-loop-helix class of transcription factors. Proc Natl Acad Sci U S A. 1997;94:5172-5176.
28. Li Q, Hu N, Daggett MAF, et al. Participation of upstream stimulator factor (USF) in cadmium-induction of the mouse metallothionein-I gene. Nucleic Acids Res. 1998;26:5182-5189.
29. Sirito M, Lin Q, Maity T, Sawadogo M. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res. 1994;22:427-433.
30. Sawadogo M. Multiple forms of the human gene-specific transcription factor USF, II: DNAbinding properties and transcriptional activity of the purified HeLa USF. J Biol Chem. 1988;263:11994-12001.
31. Sawadogo M, Van Dyke MW, Gregor PD, Roeder RG. Multiple forms of the human gene-specific transcription factor USF, I: complete purification and identification of USF from HeLa cell nuclei. J Biol Chem.1988;263:11985-11993.
32. Viollet B, Lefrançois-Martinez A-M, Henrion A, Kahn A, Raymondjean M, Martinez A. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem. 1996;271:1405-1415.
33. Lefrancois-Martinez AM, Martinez A, Antoine B, Raymondjean M, Kahn A. Upstream stimulatory factor proteins are major components of the glucose response complex of the L-type pyruvate kinase gene promoter. J Biol Chem. 1995;270:2640-2643.
34. Walhout A, Gubbels J, Bernards R, van der Vliet P, Timmers H. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene. Nucleic Acids Res. 1997;25:1493-1501.
35. Yamashita H, Takenoshita M, Sakurai M, et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A. 2001;98:9116-9121.
36. Wang D, Sul HS. Upstream stimulatory factors bind to insulin response sequence of the fatty acid synthase promoter: USF1 is regulated. J Biol Chem. 1995;270:28716-28722.
37. Casado M, Vallet VS, Kahn A, Vaulont S. Essential role in vivo of upstream stimulatory factors for a normal dietary response of the fatty acid synthase gene in the liver. J Biol Chem. 1999;274:2009-2013.
38. Vallone D, Gondi SB, Whitmore D, Foulkes NS. E-box function in a period gene repressed by light. Proc Natl Acad Sci U S A. 2004;101:4106-4111.
39. Farina A, Gaetano C, Crescenzi M, et al. The inhibition of cyclin B1 gene transcription in quiescent NIH 3T3 cells is mediated by an E-box. Oncogene. 1996;13:1287-1296.
40. McDonald MJ, Rosbash M, Emery P. Wild-type circadian rhythmicity is dependent on closely spaced E boxes in the Drosophila timeless promoter. Mol Cell Biol. 2001;21:1207-1217.
41. β2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene. J Biol Chem. 1996;271:32375-32380.
42. Camara-Clayette V, Rahuel C, Bertrand O, Cartron J-P. The E-box of the human glycophorin B promoter is involved in the erythroid-specific expression of the GPB gene. Biochem Biophys Res Commun. 1999;265:170-176.
43. Biben C, Kirschbaum BJ, Garner I, Buckingham M. Novel muscle-specific enhancer sequences upstream of the cardiac actin gene. Mol Cell Biol. 1994;14:3504-3513.
44. 2-microglobulin transactivation in hematopoietic cells. Blood. 2003;101:3058-3064.
45. Blackwood EM, Luscher B, Eisenman RN. Myc and Max associate in vivo. Genes Dev. 1992;6:71-80.
46. Camilla A, Velmurugesan A, Whitelaw ML, Pettersson S, Poellinger L. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. J Biol Chem. 1995;270:13968-13972.
47. Hsu HL, Huang L, Tsan JT, et al. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol. 1994;14:1256-1265.
48. Gekakis N, Staknis D, Nguyen H, et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 1998;280:1564-1569.
49. Darlington T, Wager-Smith K, Ceriani K, et al. Closing the circadian loop: CLOCK-induced transcription of its own inhibitors per and tim. Science. 1998;280:1599-1603.
50. Artandi S, Cooper C, Shrivastava A, Calame K. The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction. Mol Cell Biol. 1994;14:7704-7716.
51. Antonsson C, Arulampalam V, Whitelaw ML, Pettersson S, Poellinger L. Constitutive function of the basic helix-loop-helix/PAS factor Arnt. J Biol Chem. 1995;270:13968-13972.
52. Ripperger JA, Shearman LP, Reppert SM, Schibler U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. 2000;14:679-689.
53. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647-676.
54. Huang J, Blackwell T, Kedes L, Weintraub H. Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection. Mol Cell Biol. 1996;16:3893-3900.
55. Muñoz E, Brewer M, Baler R. Circadian transcription: thinking outside the E-box. J Biol Chem. 2002;277:36009-36017.
56. Blackwell TK, Huang J, Ma A, et al. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol. 1993;13:5216-5224.
57. Boyd KE, Farnham PJ. Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol. 1997;17:2529-2537.
58. Sirito M, Lin Q, Deng JM, Behringer RR, Sawadogo M. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc Natl Acad Sci U S A. 1998;95:3758-3763.
59. Pajukanta P, Lilja HE, Sinsheimer JS, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36:371-376.
60. Hitman GA, Sudagani J. Searching for genes in diabetes and the metabolic syndrome. Int J Clin Pract. 2004;58:3-8.
61. Wu K-J, Polack A, Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science. 1999;283:676-679.
62. Timchenko N, Wilson DR, Taylor LR, et al. Autoregulation of the human C/EBP alpha gene by stimulation of upstream stimulatory factor binding. Mol Cell Biol. 1995;15:1192-1203.